Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Many male cancer patients are missing out on sperm banking

28.10.2010
Many men – whose fertility may be at risk from cancer treatment – are not being offered the chance to store their sperm according to new research published today in the Annals of Oncology (Thursday).

Guidelines from the National Institute for Health and Clinical Excellence (NICE) state that any men or adolescent boys who are receiving treatment that may leave them infertile should be offered the opportunity to store their sperm.

But in a study funded by Cancer Research UK, researchers at the University of Warwick and University Hospitals Coventry and Warwickshire NHS Trust found that only half of oncologists and haematologists across the UK agreed that information on sperm banking is readily available to patients, despite national guidelines which state sperm banking should be offered.

In a survey of nearly 500 clinicians, the researchers also found that 21 per cent were unaware of any local policies on sperm banking.

And only a quarter (26 per cent) of oncologists and 38 per cent of haematologists reported that discussions about sperm banking with male cancer patients are being documented systematically, yet nearly all doctors believed it was an integral part of their role to raise this topic.

Dr Ann Adams, study author from Warwick Medical School, said: "Our findings are very concerning and show that doctors in the UK aren't following sperm banking guidance, meaning many men are missing the opportunity to store their sperm for the future. Instead it appears that clinicians are deciding who is offered the chance to bank sperm based on their own personal beliefs, attitudes and assumptions about their patients' likelihood of starting a family in the future.

"Doctors know that many chemotherapy drugs can cause problems with fertility, so it's vital that all teenagers and men of any age who may want to start a family in the future are given the chance to bank their sperm."

Professor Geraldine Hartshorne, also an author from Warwick Medical School, added: "We're urging clinicians to discuss sperm banking with all their male cancer patients. Improved awareness and access to training for clinicians would hopefully increase both the opportunity and the uptake of sperm banking for cancer patients."

Martin Ledwick, head information nurse at Cancer Research UK, said: "We hope this new research raises the awareness of the sorts of discussions cancer patients should be having with their doctors and results in all men being offered the opportunity to bank their sperm for their future use. More and more people are surviving cancer so finding ways to improve their quality of life after treatment is becoming increasingly important."

For media enquiries please contact Laura Dibb on 020 7061 8051 or, out-of-hours, the duty press officer on 07050 264 059

For interviews with the authors please contact Kelly Parkes-Harrison, Communications Manager, University of Warwick on 02476 150483 or 07824 540863, k.e.parkes@warwick.ac.uk

Notes to Editors:
'Who should be offered sperm banking for fertility preservation? A survey of UK oncologists and Haematologists'. Hartshorne, G and Adams, A at al. Annals of Oncology (2010). DOI:10.1093/annonc/mdq579

About Cancer Research UK

Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research
The charity's groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public.
Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last forty years.
Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.

Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.

For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7121 6699 or visit www.cancerresearchuk.org

Peter Dunn | EurekAlert!
Further information:
http://www.warwick.ac.uk

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>